CRP correlates with clinical score in ulcerative colitis but not in Crohn disease's

被引:54
|
作者
Rodgers, Alexander D. [1 ]
Cummins, Adrian G. [1 ]
机构
[1] Queen Elizabeth Hosp, Dept Gastroenterol & Hepatol, Woodville, SA 5011, Australia
关键词
C-reactive protein; Crohn's disease; erythrocyte sedimentation rate; inflammatory bowel disease; ulcerative colitis;
D O I
10.1007/s10620-006-9691-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The aim of this study was to prospectively evaluate the correlation between clinical scoring systems and C-reactive protein (CRP) in inflammatory bowel disease. The modified Harvey-Bradshaw index was used in 40 patients (58 assessments) with Crohn's disease, and the Lichtiger score in 29 patients (36 assessments) with ulcerative colitis. In ulcerative colitis, CRP was elevated in 14%, 42%, 64%, and 83%, respectively, of subjects with quiescent, mild, moderate, and severe disease. There was a linear correlation of log(CRP) with clinical score except for proctitis. In Crohn's disease, CRP was elevated in 54%, 70%, 75%, and 100%, respectively, of subjects with quiescent, mild, moderate, and severe disease. We conclude that the clinical score has a good correlation with CRP in ulcerative colitis except for proctitis, whereas clinical score has a poor correlation with CRP in Crohn's disease, particularly in those with clinically quiescent, fibrostenotic, and ileal disease.
引用
收藏
页码:2063 / 2068
页数:6
相关论文
共 50 条
  • [41] Aminosalicylates in the treatment of ulcerative colitis and Crohn's disease
    Sutherland, LR
    ADVANCES IN INFLAMMATORY BOWEL DISEASES, 1999, 106 : 201 - 209
  • [42] Prevalence of ulcerative colitis and Crohn’s disease in Japan
    Keiko Asakura
    Yuji Nishiwaki
    Nagamu Inoue
    Toshifumi Hibi
    Mamoru Watanabe
    Toru Takebayashi
    Journal of Gastroenterology, 2009, 44 : 659 - 665
  • [43] Biological therapy in Crohn's disease and ulcerative colitis
    Dolz, C.
    MEDICINA BALEAR, 2008, 23 (03): : 19 - 23
  • [44] Crohn's disease and ulcerative colitis: Antibodies and men
    Duclos, B
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1995, 19 (11): : 865 - 866
  • [45] The Genetics Universe of Crohn's Disease and Ulcerative Colitis
    Parkes, Miles
    DIGESTIVE DISEASES, 2012, 30 : 78 - 81
  • [46] Prevalence of ulcerative colitis and Crohn's disease in Japan
    Asakura, Keiko
    Nishiwaki, Yuji
    Inoue, Nagamu
    Hibi, Toshifumi
    Watanabe, Mamoru
    Takebayashi, Toru
    JOURNAL OF GASTROENTEROLOGY, 2009, 44 (07) : 659 - 665
  • [47] Vedolizumab for the treatment of ulcerative colitis and Crohn's disease
    McLean, Leon P.
    Shea-Donohue, Terez
    Cross, Raymond K.
    IMMUNOTHERAPY, 2012, 4 (09) : 883 - 898
  • [48] Immunosuppression therapy in ulcerative colitis and Crohn's disease
    Present, DH
    ADVANCES IN INFLAMMATORY BOWEL DISEASES, 1999, 106 : 218 - 226
  • [49] Probiotics in the Management of Crohn's disease and Ulcerative Colitis
    Muellner, Katalin
    Miheller, Pal
    Herszenyi, Laszlo
    Tulassay, Zsolt
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (28) : 4556 - 4560
  • [50] CT features of ulcerative colitis and Crohn's disease
    Gore, RM
    Balthazar, EJ
    Ghahremani, GG
    Miller, FH
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1996, 167 (01) : 3 - 15